Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticles
Introduction: In etiology of Alzheimer’s disease (AD), involvement of amyloid β (Aβ) plaque accumulation and oxidative stress in the brain have important roles. Several nanoparticles such as titanium dioxide, silica dioxide, silver and zinc oxide have been experimentally using for treatment of neuro...
| Published in: | Expert Review of Clinical Pharmacology |
|---|---|
| Main Author: | |
| Format: | Review |
| Language: | English |
| Published: |
Taylor and Francis Ltd
2017
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021103809&doi=10.1080%2f17512433.2017.1324781&partnerID=40&md5=c4279183e800673b1cd805c82ffadca3 |